Terry L. Smith

21.1k total citations · 5 hit papers
154 papers, 16.0k citations indexed

About

Terry L. Smith is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Terry L. Smith has authored 154 papers receiving a total of 16.0k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Oncology, 44 papers in Cancer Research and 42 papers in Pathology and Forensic Medicine. Recurrent topics in Terry L. Smith's work include Breast Cancer Treatment Studies (40 papers), Acute Myeloid Leukemia Research (28 papers) and Cancer Treatment and Pharmacology (26 papers). Terry L. Smith is often cited by papers focused on Breast Cancer Treatment Studies (40 papers), Acute Myeloid Leukemia Research (28 papers) and Cancer Treatment and Pharmacology (26 papers). Terry L. Smith collaborates with scholars based in United States, United Kingdom and China. Terry L. Smith's co-authors include M. Schemper, Aman U. Buzdar, Gabriel N. Hortobágyi, Michael J. Keating, Hagop M. Kantarjian, Emil J. Freireich, Richard L. Theriault, S. Eva Singletary, Ying Yang and George R. Blumenschein and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Investigation.

In The Last Decade

Terry L. Smith

153 papers receiving 15.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A note on quantifying follow-up in studies of failure time

1996 1.9k citations Terry L. Smith et al. profile →
Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

1999 1.1k citations Henry M. Kuerer, Terry L. Smith et al. Journal of Clinical Oncology profile →
Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

2005 867 citations Aman U. Buzdar, Lajos Pusztai et al. Journal of Clinical Oncology profile →
Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.

1996 596 citations Gabriel N. Hortobágyi, Terry L. Smith et al. Journal of Clinical Oncology profile →
Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia

2000 586 citations Hagop M. Kantarjian, Terry L. Smith et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Terry L. Smith

Since Specialization

Citations

This map shows the geographic impact of Terry L. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry L. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry L. Smith more than expected).

Fields of papers citing papers by Terry L. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry L. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry L. Smith. The network helps show where Terry L. Smith may publish in the future.

Co-authorship network of co-authors of Terry L. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Terry L. Smith. A scholar is included among the top collaborators of Terry L. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry L. Smith. Terry L. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diacylglycerol Lipase-β Knockout Mice Display a Sex-Dependent Attenuation of Traumatic Brain Injury-Induced Mortality with No Impact on Memory or Other Functional Consequences 2021 ·Cannabis and Cannabinoid Research ·Lesley D. Schurman, Terry L. Smith, Giulia Donvito, Benjamin F. Cravatt, Jason Newton, Sarah Spiegel, Thomas M. Reeves, Linda L. Phillips, Aron H. Lichtman	3
2	Matrix Metalloproteinase 9 and Osteopontin Interact to Support Synaptogenesis in the Olfactory Bulb after Mild Traumatic Brain Injury 2018 ·Journal of Neurotrauma ·Melissa A. Powell, (unknown), Terry L. Smith, Thomas M. Reeves, Linda L. Phillips	11
3	Mild Fluid Percussion Injury Induces Diffuse Axonal Damage and Reactive Synaptic Plasticity in the Mouse Olfactory Bulb 2017 ·Neuroscience ·Melissa A. Powell, (unknown), Terry L. Smith, Thomas M. Reeves, Linda L. Phillips	8
4	Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen 2005 ·Cancer ·Apostolia M. Tsimberidou, Anas Younes, Jorge Romaguera, Fredrick B. Hagemeister, Maria Alma Rodriguez, Lei Feng, Ana Ayala, Terry L. Smith, Fernando Cabanillas, Peter McLaughlin	22
5	Prognostic factors and treatment of patients with T‐cell non‐Hodgkin lymphoma 2005 ·Cancer ·Maricer P. Escalón, (unknown), Ying Yang, Mark A. Hess, Pamela L. Walker, Terry L. Smith, Nam H. Dang	169
6	The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy 2004 ·Biology of Blood and Marrow Transplantation ·Yee Chung Cheng, Gabriela Rondón, Ying Yang, Terry L. Smith, James Gajewski, Michèle L. Donato, Elizabeth J. Shpall, Roy B. Jones, Gabriel N. Hortobágyi, Richard E. Champlin, Naoto T. Ueno	14
7	Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response 2004 ·Cancer ·Radhika Rajan, Anna W. Poniecka, Terry L. Smith, Ying Yang, (unknown), Lajos Pusztai, (unknown), (unknown), Gary J. Whitman, Roman Rouzier, Marjorie Green, Henry M. Kuerer, Aman U. Buzdar, Gabriel N. Hortobágyi, W. Fraser Symmans	117
8	ErbB2 overexpression in human breast carcinoma is correlated with p21^Cip1 up‐regulation and tyrosine‐15 hyperphosphorylation of p34^Cdc2 2003 ·Cancer ·Wentao Yang, Kristine S. Klos, Xiaoyan Zhou, Jun Yao, Ying Yang, Terry L. Smith, Daren Shi, Dihua Yu	33
9	Treating refractory advanced or metastatic urothelial carcinoma with interleukin-2: a phase II study 2003 ·Urologic Oncology Seminars and Original Investigations ·Jeri Kim, Randall E. Millikan, Terry L. Smith, Shi‐Ming Tu, Lance C. Pagliaro, Christopher J. Logothetis	4
10	Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma 2003 ·Journal of the American Academy of Dermatology ·Madeleine Duvic, Narin Apisarnthanarax, Deborah S. Cohen, Terry L. Smith, Chul S. Ha, Razelle Kurzrock	48
11	Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia 2002 ·Cancer ·Francesco Onida, Greg Ball, Hagop M. Kantarjian, Terry L. Smith, Armand B. Glassman, Maher Albitar, Barbara Scappini, Mary Beth Rios, Michael J. Keating, Miloslav Beran	65
12	HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation. 2001 ·PubMed ·Young Sil Kim, Sergej Konoplev, Filippo Montemurro, (unknown), Terry L. Smith, Gabriela Rondón, Richard Champlin, Ayşegül A. Şahin, Naoto T. Ueno	33
13	Primary refractory and relapsed adult acute lymphoblastic leukemia 1999 ·Cancer ·Deborah A. Thomas, Hagop M. Kantarjian, Terry L. Smith, Charles Koller, Jörge E. Cortes, Susan O’Brien, Francis J. Giles, James Gajewski, Sherry Pierce, Michael J. Keating	144
14	Hodgkin’s disease with lymphocyte predominance: long-term results based on current histopathologic criteria 1999 ·International Journal of Radiation OncologyBiologyPhysics ·Chul S. Ha, Vivek S. Kavadi, Meletios Α. Dimopoulos, Frederick Hagemeister, (unknown), Lillian M. Fuller, Terry L. Smith, Mark A. Hess, Peter W. McLaughlin, Fernando Cabanillas, James D. Cox	16
15	Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patients. 1998 ·PubMed ·Todd M. Tuttle, (unknown), (unknown), Jeffrey E. Lee, Ayşegül A. Şahin, Terry L. Smith, Kenneth H. Grabstein, J.Taylor Wharton, Constantin G. Ioannides, James L. Murray	44
16	Significance of cytogenetic clonal evolution in chronic myelogenous leukemia. 1996 ·Journal of Clinical Oncology ·Alejandro Majlis, Terry L. Smith, Moshe Talpaz, Stephen O’Brien, Mary Beth Rios, Hagop M. Kantarjian	63
17	SMS 201-995 in the treatment of refractory prostatic carcinoma. 1994 ·PubMed ·Christopher J. Logothetis, Elizabeth Hossan, Terry L. Smith	33
18	The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer 1993 ·Cancer ·Aman U. Buzdar, Shu Wan Kau, Gabriel N. Hortobágyi, Terry L. Smith, Frederick C. Ames, Eva S. Singletary, Eric A. Strom, Marsha D. McNeese	48
19	Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer? 1990 ·Cancer ·Aman U. Buzdar, Marsha D. McNeese, Gabriel N. Hortobágyi, Terry L. Smith, Shu Wan Kau, Giuseppe Fraschini, Verena Hug, Nancy A. Ellerbroek, Frankie A. Holmes, Frederick C. Ames, S. Eva Singletary	49
20	Combination chemotherapy with bleomycin (NSC-125066), vincristine (NSC-67574), and methotrexate (NSC-740) plus split-course radiotherapy in the treatment of non-oat-cell bronchogenic carcinoma. 1975 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·M. L. Samuels, H. Thomas Barkley, Paul Y. Holoye, (unknown), Terry L. Smith	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact